Skip to content

MedGuideMedicine information

Drugs A-Z Conditions Drug classes Guides

Drugs A-Z Conditions Drug classes Guides Contact Admin

Home
/ Conditions
/ FDA approved: September 2024

Condition

FDA approved: September 2024

Medicines used for fda approved: september 2024

Ocrevus Zunovo — ocrelizumab and hyaluronidase

Using this page

The medicines listed here are linked from their drug pages. This is not a treatment recommendation: the right choice depends on your history, other medicines and how severe the condition is.

If symptoms are severe or not improving, speak to a pharmacist or doctor.

All conditions

Medicine information you can understand. Every page explains what a medicine is, what it treats and how it is normally taken.

MedGuide publishes general medicine information for educational purposes. It is not a substitute for advice from a doctor, pharmacist or other qualified clinician.

Browse

Drugs A-Z
Conditions
Drug classes
Guides & news
Search

About

About MedGuide
Editorial policy
Contact

Safety

Medical disclaimer
Editorial policy
Privacy policy
Terms of use
Sitemap

© 2026 MedGuide. All rights reserved. Information is for education only — not a substitute for medical advice.

Medical disclaimer: The content on MedGuide is general information and does not replace advice from a qualified healthcare professional. Always read the label supplied with your medicine and speak to your doctor or pharmacist about your personal circumstances. If you think you are having a medical emergency, contact your local emergency service immediately.